echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Thorax: Incidence, treatment, and survival of malignant pleural and peritoneal mesothelioma

    Thorax: Incidence, treatment, and survival of malignant pleural and peritoneal mesothelioma

    • Last Update: 2022-03-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Malignant mesothelioma is a highly lethal tumor that originates mainly from the pleura and to a lesser extent from the peritoneum
    .


    In sporadic cases, it originates in the pericardium or the sheath of the testis


    90%

    Recently, a research article was published in Thorax, an authoritative journal in the field of thoracic diseases, which aimed to review the population-based incidence, treatment and survival of MPM since asbestos was banned in the Netherlands in 1993
    .

    The researchers included patients diagnosed with MPM or MPeM between 1993 and 2018 from the Netherlands Cancer Registry and calculated the (age-specific and sex-specific) revised annual percentage change (APC) in European normalized incidence rate (RESR)
    .


    In addition, we performed treatment patterns and Kaplan-Meier overall survival analyses


    A total of 12,168 patients were included in the study
    .


    For male patients under the age of 80, the incidence of malignant mesothelioma decreased significantly over the past decade (APC between -9.


    Since 2003, the use of systemic chemotherapy has increased, especially for MPM (from 9.
    3% to 39.
    4%)
    .


    Overall, 62.


    It can be seen that the peak incidence of malignant mesothelioma in the Netherlands was around 2010, and the incidence of most age groups is currently declining
    .


    The use of systemic chemotherapy has increased since 2003, which may improve overall patient survival over time


    The peak incidence of malignant mesothelioma in the Netherlands was around 2010, and the incidence is currently declining in most age groups


    Original source:

    Original source:

    Job P van Kooten, et al.


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.